Tonix Pharmaceuticals

TNXPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$78.980 M

$4.61 -9.88%

Close of 6 Nov 2026

As of 6 Nov 2026, Tonix Pharmaceuticals (TNXP) has a market capitalization of $79.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$13.1M

#3079 by revenue

Earnings

-$124.0M

Loss-making

Shares outstanding

17,151,024

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#303GeneluxGNLX$82.3M
#304Tiziana Life SciencesTLSA$79.3M
#305Tonix PharmaceuticalsTNXP$79.0M
#306Cumberland PharmaceuticalsCPIX$75.5M
#307MedicinovaMNOV$71.9M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Tonix Pharmaceuticals, worth $27.6K. Grants and option exercises are excluded.

Seth LedermanChief Executive Officer$27.6K
2,000 shares at $13.79 on 27 Aug 2026 · filed 31 Aug 2026

What if Tonix Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,646,367

Per share 357,517× higher

Bitcoin $1.53T

$89,082.03

Per share 19,345× higher

Apple $5.02T

$292,448.00

Per share 63,507× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Tonix Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.